Actively Recruiting

Age: 18Years +
All Genders
NCT05731622

Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-01-31

100

Participants Needed

1

Research Sites

134 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to evaluate the intravesical recurrence (IVR) rate after ureteroscopy (diagnostic or treatment) for upper tract urothelial carcinoma (UTUC) followed by an adjuvant single instillation of Mitomycin C (SI-MMC). The main question it aims to answer are: * What is the total and time to IVR after 2 years after ureteroscopy (diagnostic or treatment) for UTUC * How is the IVR compared with a historical cohort (no SI-MMC) * What is the time to IVR after 2 years in patients who subsequently received treatment by endoscopy vs. radical nephroureterectomy (RNU) * What is the additional value of a SI-MMC on time to IVR after RNU + adjuvant MMC in patients who were evaluated by ureteroscopy prior to RNU

CONDITIONS

Official Title

Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • All patients suspect for having non-metastatic disease and planned for ureteroscopy (diagnostic or treatment) and adjuvant single instillation of Mitomycin C
  • Age ≥18 years
  • Written informed consent
Not Eligible

You will not qualify if you...

  • History of histological proven urothelial carcinoma of the bladder, including carcinoma in situ
  • History of histological proven UTUC in the contralateral kidney
  • Concurrent bladder tumour found pre-operatively or per-operatively
  • Patients where it is not feasible to obtain histology by biopsies intra-operatively
  • Known Mitomycin C
  • Renal transplantation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

AmsterdamUMC

Amsterdam, Netherlands

Actively Recruiting

Loading map...

Research Team

J

Joyce Baard, MD, MSc

CONTACT

O

Orlane Figaroa, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here